Pembrolizumab SCLC Indication Withdrawn in US medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
COVID-19 Diagnostics Market Size Worth USD 8.04 Billion at 2.7% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™ Key Prominent Players Covered in the COVID-19 Diagnostics Market Research Report Are PerkinElmer Inc. , Quest Diagnostics Incorporated , Quidel Corporation , Siemens Healthcare GmbH, Abbott Thermo Fisher Scientific Inc. , bioMérieux SA , F. Hoffmann-La Roche Ltd , Danaher Corporation
March 01, 2021 06:57 ET | Source: Fortune Business Insights Fortune Business Insights
Pune, India, March 01, 2021 (GLOBE NEWSWIRE) The global
COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights™ in its report, titled “COVID-19 Diagnostics
email article
After close to a decade at the helm, Richard Schilsky, MD, has retired from his role as chief medical officer of the American Society of Clinical Oncology (ASCO).
His legacy as the organization s first CMO will be what he calls the ASCO research enterprise launching ASCO s first-ever clinical trial, increasing its ability to conduct observational studies, and tapping into the 40,000-person membership for original survey-based research. It was clear that while ASCO was a tremendous vehicle to disseminate and amplify research findings that were generated by various entities, ASCO itself didn t actually do any research to contribute any knowledge to the field, Schilsky told
Who Will Be the Next F D A Chief? msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Richard Nixon Foundation Announces Commemoration To Mark 50th Anniversary Of National Cancer Act of 1971
Two-day meeting of experts this December will examine past, present and future of cancer treatment and research
Chaired by Former National Cancer Institute Director Dr. Andrew von Eschenbach
News provided by
Share this article
Share this article
YORBA LINDA, Calif., Feb. 18, 2021 /PRNewswire/ The Richard Nixon Foundation will host a two-day commemoration of the 1971 National Cancer Act at the Richard Nixon Presidential Library and Museum in Yorba Linda, California, on December 1 and 2, 2021.
Making the announcement on the 50th anniversary of President Nixon s 1971 Special Message to Congress Proposing a National Health Strategy -which included a call for $100 million to fight cancer - Foundation President and CEO Hugh Hewitt noted that December will mark the 50th anniversary of President Nixon signing the groundbreaking National Cancer Act of 1971.